Pemphigus Vulgaris
📧 Sign up to get email alerts when something new happens for Pemphigus Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Autoimmune Blistering Diseases Study
This clinical trial update from the University of Pennsylvania indicates the study is currently recruiting for autoimmune blistering disease…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Effect of Topical Insulin on Healing Rate of Pemphigus Lesions [Phase 2]
Phase 2 trial evaluating topical insulin to improve healing of pemphigus vulgaris lesions has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients
A clinical trial is studying periodontal status and disease severity in Pemphigus vulgaris patients. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) [Phase 1, Phase 2]
A Phase 1/2 open-label study evaluating autologous CAR-T therapies DSG3-CAART and CABA-201 for active pemphigus vulgaris; the trial is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders [Phase 2]
This Phase 2 trial evaluating a COVID-19 booster vaccine in autoimmune-disease non-responders was terminated, with results posted on 2025-08…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients. [NA]
This document reports a clinical trial evaluating low-level laser therapy for oral involvement in Pemphigus vulgaris; the study is not yet r…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or pemph…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.
Clinical study evaluating trichoscopy as a monitoring tool for activity and remission in pemphigus vulgaris, supported by immunological eval…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Comparing DCP and DAP for Pemphigus Vulgaris [Phase 4]
A Phase 4 trial comparing DCP and DAP for Pemphigus Vulgaris has completed, potentially informing comparative efficacy and safety between th…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. [Phase 1, Phase 2]
This document describes a randomized Phase 1/2 clinical trial evaluating CM313, a humanized CD38 antibody, for Pemphigus vulgaris; the study…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris
The study evaluates the efficacy and safety of an anti-CD20 monoclonal antibody combined with azathioprine and corticosteroids for Pemphigus…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 study evaluating subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or foliaceus has completed and posted results…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. [Phase 1]
Open-label Phase 1 study evaluating the safety and preliminary efficacy of combining Rituximab with AB-101 in B-cell–associated autoimmune d…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Dexamethasone Solution and Dexamethasone in Mucolox™ [Phase 2]
Phase 2 trial updates for Dexamethasone Solution and Dexamethasone in Mucolox show completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-13Clinical Trial Update: A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris [Phase 2]
Phase 2 study of PRN1008 in adults with pemphigus vulgaris completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid [Phase 3]
Phase 3 trial update investigating ozonated olive oil for Pemphigus Vulgaris and Bullous Pemigoid; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV) [Phase 4]
Clinical trial update for abatacept in pemphigus vulgaris (Phase 4) evaluating efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus [Phase 1]
Phase 1 trial update for polyclonal regulatory T cells (PolyTregs) in pemphigus shows terminated study with posted results.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris [Phase 2]
Phase 2 clinical trial evaluating the efficacy of an interleukin-2 gargle for treating oral mucosa lesions in pemphigus vulgaris.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus [Phase 2]
Phase 2 trial assessing safety, pharmacodynamics, pharmacokinetics, and efficacy of ARGX-113 in patients with pemphigus vulgaris and pemphig…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris [Phase 2]
Phase 2 trial of VAY736 in Pemphigus Vulgaris has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) [Phase 1, Phase 2]
A safety and dose-finding study of SYNT001 in pemphigus (vulgaris or foliaceus) was conducted in Phase 1/2 and subsequently terminated; resu…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) [Phase 3]
Phase 3 trial comparing Rituximab to Mycophenolate Mofetil in Pemphigus Vulgaris has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris [Phase 3]
Phase 3 trial of ofatumumab for pemphigus vulgaris was terminated with posted results.